Time will tell if the promise is real
Overall, PAP represents a good therapeutic option for patients with symptomatic OSA and comorbid hypertension, but is not a one-size-fits-all solution to the problem of OSA [29]
Androgenetic alopecia (AGA) commonly referred to as pattern hair loss is by far the most prevalent form, affecting up to 80 percent of men and 50 percent of women at some point in their lives
Sprints include: - Hyper-personalized habit building across nutrition, movement, sleep, and stress - Clinically managed access to telemedicine and (if needed) GLP-1s with clear guidance to stop before trying to get pregnant - Employer-configurable coverage, so GLP-1s are one optional tool in the kit instead of the whole strategy When members build metabolic health before pursuing fertility treatment, they are better prepared
It has years of data showing real cardiovascular benefits, while retatrutides long-term impact is still unknown